Wu et al. verified the important role of SIRT1 in hepatic stellate cell activation and reversal and its overexpression counteracting TGF-β1-induced LX-2 cell activation (Wu et al., 2015), suggesting its potential as an alternative for the treatment of liver fibrosis. Here, TGFB1 is linked to Hepatic fibrosis.